Form D Explorer

Source evidence

FibroBiologics, Inc. · 0001493152-26-031095

D filed June 29, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
HOUSTON
street1
9350 KIRBY DRIVE
street2
SUITE 300
zipCode
77054
entityName
FibroBiologics, Inc.
entityType
Corporation
stateOrCountry
Texas
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold3000000number3000000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions315000number315000/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount3000000number3000000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count1number1/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 8c2609488061e0ad7249d00291e9b72e0d25701e755fb48c5d41b5a36a94d8df. This proves extraction identity, not the accuracy of the filer's claims.